Ten-year quality of life outcomes in men with prostate cancer
File version
Accepted Manuscript (AM)
Author(s)
Ng, Shu Kay
Zajdlewicz, Leah
Lepore, Stephen J
Heathcote, Peter
Kneebone, Andrew
Dunn, Jeffrey C
Chambers, Suzanne K
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
- BACKGROUND: Although men with prostate cancer are living longer, they are not necessarily living well, with symptom burden increasing and HRQoL declining over time(1). For many men, the first five years after diagnosis is marked by unmet needs, debilitating disease and treatment-related bowel, urinary and sexual symptoms(2). To date, few studies have examined the trajectories of men over the 10 years after diagnosis(3). To advance survivorship care, it is crucial to understand what factors drive long-term (10 year) health outcomes after a prostate cancer diagnosis. Accordingly, this study extends our previous research (4) to report physical and mental HRQoL, life satisfaction and symptom burden of men over the 10 years after prostate cancer diagnosis.
- METHOD:
2.1 Study setting and participants
This study of newly diagnosed adult men with prostate cancer was conducted in Queensland, Australia. Sampling strategy and methods are previously described(4). Ethical approval was obtained from the Queensland University of Technology Human Research Ethics Committee (Approval No.3629H). In total, 1291 men were approached, 1064 consented, and 598 (56%) completed the final 10-year questionnaire. Self-administered questionnaires and computer-assisted telephone interviews were completed at baseline, and 2,6,12,24,36,48,60,72,84,96,108 and 120 months after the commencement of treatment.
2.2 Measures and statistical analyses: Participants’ demographics and clinical characteristics have been previously described(4). Outcome measures included Disease-specific (Expanded Prostate Cancer Index Composite; EPIC) and HRQoL (Short Form 36; SF-36); Satisfaction with Life (Satisfaction with Life Scale; SWLS) (See Figure 1a,b,c)(5-7). Growth mixture models (GMMs) in Mplus (Muthen and Muthen, 2015, Mplus User’s Guide http://www.statmodel.com/usersguide/chapter8.shtml) were adopted to identify trajectory classes and predictors using 10-year follow-up data, with EPIC longitudinal subscales as time-varying covariates(4). Missing EPIC were computed using multiple-imputation (10 repetitions), but participants with >9 missing values in EPIC or with missing data in other predictors were excluded (sample size reduced to n=928). The number of trajectory classes was determined using the Lo-Mendell-Rubin likelihood ratio test.
Journal Title
Psycho-Oncology
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2019 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Ten‐year quality of life outcomes in men with prostate cancer, Psycho-Oncology, 2019, which has been published in final form at https://doi.org/10.1002/pon.5255. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Oncology and carcinogenesis
Psychology
Biomedical and clinical sciences
Persistent link to this record
Citation
Ralph, NF; Ng, SK; Zajdlewicz, L; Lepore, SJ; Heathcote, P; Kneebone, A; Dunn, JC; Chambers, SK, Ten-year quality of life outcomes in men with prostate cancer, Psycho-Oncology, 2019